All are adcatages off arrays in front of cytogebetics...the only dissatvantage is that do not detect balanced alterations and that we have to have at least 20 or 30% of cells woth the same alteration to be detected....other could be price....the other are advantages.
Thank you Dr Francesc. But I have read about the CNV de novo and also about other DNA variants with unknown effect on fetus phenotype, in this cases the genetic counseling is very complex. How is the management of this cases? Is this situation a disadvantage or not?